EUVIMEDEUVIMED entdecken
Open Access

Hepatocyte-specific epidermal growth factor receptor (EGFR) deletion attenuates acetaminophen-induced liver injury in mice

Siddhi Jain, Gillian Williams, Ranjan Mukherjee, Anne Orr, Jia-Jun Liu, Silvia Liu iD, Joseph Locker, Bharat Bhushan

Toxicological Sciences · 2026

DOI: 10.1093/toxsci/kfaf151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, 2026. Verfasst von Siddhi Jain und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, United States. Hauptthemen laut MEDLINE: Acetaminophen, ErbB Receptors, Hepatocytes, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, University of Pittsburgh Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidermal growth factor receptor (EGFR) is mostly known for its proliferative role in the liver. Our earlier investigations indicated a paradoxical cell-death-promoting facet of EGFR in the acetaminophen (APAP)-induced liver injury (AILI) model. The current study investigates this unexpected role of EGFR in promoting AILI using a hepatocyte-specific EGFR deletion mouse model. Hepatocyte-specific EGFR-deficient mice were generated by administering AAV8.TBG.Cre in EGFRfl/fl mice and were subsequently treated with a severely toxic dose (500 mg/kg) of APAP. Liver injury, regeneration, and associated signaling pathways were assessed at different time intervals. EGFR deletion did not alter early liver injury at 6 h but significantly attenuated the progression of liver injury at 12 and 24 h following APAP overdose. Consistently, the key injury-initiating events, such as APAP-protein adducts formation and early JNK activation, remained unimpaired in EGFR-deficient mice. However, EGFR deletion restricted prolonged JNK activation and its mitochondrial translocation, resulting in reduced propagation of mitochondrial damage and release of cell death drivers. Further, the replenishment of antioxidant glutathione (GSH), which is known to limit the progression of liver injury, was strikingly faster in EGFR-deficient mice. RNA-seq analysis and consequent validation revealed marked upregulation of autophagy and its transcriptional regulator, transcription factor EB, a key response to remove damaged mitochondria, in EGFR-deficient mice. Paradoxically, EGFR deletion also promoted compensatory hepatocyte proliferation, possibly secondary to decreased severity of liver injury. Overall, hepatocyte-specific EGFR deletion halted the progression of AILI. Our study established an unexpected role of EGFR in promoting AILI progression, which has wide implications in liver biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenErbB ReceptorsHepatocytesChemical and Drug Induced Liver InjuryAnimalsMice, KnockoutMiceMaleLiverMice, Inbred C57BLLiver RegenerationGene Deletion

Stichwörter der Autor:innen

GCLCJNKTFEBacute liver failureautophagyliver regeneration

Substanzen

AcetaminophenErbB ReceptorsEGFR protein, mouse

Autor:innen und Institutionen

  • Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, United States.
  • Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 15261, United States.
  • Organ Pathobiology and Therapeutics Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, United States.
  • Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, United States.

ORCID-Profile: Silvia Liu

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • University of Pittsburgh Center
  • National Institutes of Health
  • Pittsburgh Liver Research Center (PLRC) National Institutes of Health

Zitieren

APA

Jain, S., Williams, G., Mukherjee, R., Orr, A., Liu, J. J., Liu, S., Locker, J., & Bhushan, B. (2026). Hepatocyte-specific epidermal growth factor receptor (EGFR) deletion attenuates acetaminophen-induced liver injury in mice. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfaf151

Vancouver

Jain S, Williams G, Mukherjee R, Orr A, Liu JJ, Liu S, et al. Hepatocyte-specific epidermal growth factor receptor (EGFR) deletion attenuates acetaminophen-induced liver injury in mice. Toxicological Sciences. 2026. doi:10.1093/toxsci/kfaf151

BibTeX
@article{Jain2026,
  author = {Jain, Siddhi and Williams, Gillian and Mukherjee, Ranjan and Orr, Anne and Liu, Jia-Jun and Liu, Silvia and Locker, Joseph and Bhushan, Bharat},
  title = {Hepatocyte-specific epidermal growth factor receptor (EGFR) deletion attenuates acetaminophen-induced liver injury in mice},
  journal = {Toxicological Sciences},
  year = {2026},
  doi = {10.1093/toxsci/kfaf151}
}
Kostenlos starten →